Scipher Medicine Brings Precision Medicine Platform to Patient-Centered MIT Initiative
03 févr. 2021 08h00 HE
|
Scipher Medicine Corporation
WALTHAM, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with the most effective therapy, announced today they have partnered with...
Mariann Byerwalter joins Scipher Medicine’s Board of Advisors
01 déc. 2020 08h00 HE
|
Scipher Medicine Corporation
WALTHAM, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with the most effective therapy, has appointed Mariann Byerwalter to its Board of...
Daxor Corporation to Exhibit at the 23rd Annual Scientific Meeting of the Heart Failure Society of America
11 sept. 2019 08h00 HE
|
Daxor Corporation
NEW YORK, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Metabolon Identifies Biomarkers with Superior Diagnostic Performance Over Creatinine for Chronic Kidney Disease
28 avr. 2016 15h50 HE
|
Metabolon, Inc.
Data presented at National Kidney Foundation 2016 Spring Clinical MeetingsMetabolites form basis of accuGFR™ test in development RESEARCH TRIANGLE PARK, N.C., April 28, 2016 (GLOBE NEWSWIRE) --...
Metabolon and SYNLAB Group Form Commercialization Collaboration for Quantose™ IR Diagnostic
29 mars 2016 09h59 HE
|
Metabolon, Inc.
SYNLAB Group to market Quantose IR, a laboratory-developed test used to identify insulin resistanceInitial launch in SpainAdditional markets to follow in 2016 RESEARCH TRIANGLE PARK, N.C., March 29,...
Metabolon's Quantose(TM) Prediabetes Tests Now Available in Europe Through Collaboration With Metdia Biotech
17 sept. 2014 11h05 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc., a global leader in metabolomics, announced today that it has partnered with Metdia Biotech, S.L. to commercialize its...